Previous Article | Next Article 
Infection and Immunity, August 2001, p. 4944-4950, Vol. 69, No. 8
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.4944-4950.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Porphyromonas gingivalis Fimbriae Inhibit
Caspase-3-Mediated Apoptosis of Monocytic THP-1 Cells under Growth
Factor Deprivation via Extracellular Signal-Regulated
Kinase-Dependent Expression of p21 Cip/WAF1
Ken
Ozaki1 and
Shigemasa
Hanazawa2,*
Department of Oral Microbiology, Meikai
University School of Dentistry, Keyakidai, Sakado City, Saitama
350-0283,1 and Division of Oral
Infectious Diseases and Immunology, Faculty of Dental Science, Kyushu
University, Maidashi 3-1-1, Higashi-Ku, Fukuoka City
812-8582,2 Japan
Received 22 November 2000/Returned for modification 14 February
2001/Accepted 30 April 2001
 |
ABSTRACT |
Apoptotic regulation of monocytes/macrophages appears to be closely
associated with chronic inflammatory reactions. Since it was
demonstrated earlier that certain bacterial cell components are
involved in apoptotic regulation of these cells, in the present study,
we investigated whether the bacterial fimbria, an important cell
structure involved in bacterial adherence to host cells, regulates
apoptosis of human monocytic THP-1 cells induced under growth factor
deprivation. To investigate this point, we used fimbriae of
Porphyromonas gingivalis, a pathogen causing periodontal disease, which is a chronic inflammatory disease. The fimbriae inhibited apoptosis of the cells under growth factor deprivation. This
inhibitory action of the fimbriae was completely neutralized by
anti-fimbrial antibody. The fimbriae stimulated activation of
extracellular signal-regulated kinase (ERK) and expression of
cyclin-dependent kinase inhibitor p21 Cip/WAF1 (p21) in the cells. The
stimulatory effect of the fimbriae on the expression of the p21 protein
was inhibited by treatment with PD98059, a specific inhibitor of ERK.
The cell apoptosis was inhibited by treatment with Ac-DEVD-CHO, an
inhibitor of caspase-3. The fimbriae inhibited the serum
withdrawal-induced cleavage of the caspase-3 proform and
poly(ADP-ribose) polymerase, one of the caspase-3 substrates.
Furthermore, PD98059 and antisense p21 oligonucleotide blocked the
fimbrial inhibition of apoptosis and caspase-3 activation of the cells
induced by serum withdrawal. These results show that the bacterial
fimbriae inhibited apoptosis of THP-1 cells induced under growth factor
deprivation via ERK-dependent expression of p21. The present study
suggests that bacterial fimbriae act as potent regulators of chronic
inflammatory disease, e.g., periodontal disease, through blocking
apoptosis of monocytes/macrophages.
 |
INTRODUCTION |
It has been well documented that apoptosis plays
an important role in the inflammatory response, tumorigenesis, and
embryonic development (4). Apoptosis is characterized by
distinctive morphological and biochemical changes involving nuclear and
chromatin condensation, cell membrane blebbing, and endonuclease
activity resulting in DNA fragmentation (37). Therefore,
much interest has been generated in demonstrating the signaling
mechanisms of specific genes that regulate apoptosis.
Recent studies (30, 32, 48) have shown that several
pathogenic bacteria function as promoters or inhibitors of apoptosis of
monocytes/macrophages. These observations suggest that several cell
components of these bacteria are involved in an important pathogenic
mechanism promoting inflammation and concomitant disease via apoptosis
of monocytes/macrophages. In fact, lipopolysaccharide of gram-negative
bacteria is able to regulate the apoptosis of neutrophils and
monocytes/macrophages via direct or indirect action through endogenous
cytokines (1, 10, 13, 20, 26-28, 32, 35, 44).
Porphyromonas gingivalis is a pathogen causing periodontal
disease, a typical chronic inflammatory disease (14, 23, 24, 41,
47). The bacterial fimbria is an important cell structure that
contributes to the adherence to and invasion of host cells. Also,
several studies (11, 16-19, 31, 40) have shown that the
fimbriae function as a virulence factor in inflammatory reactions because they stimulate production of inflammatory cytokines by macrophages and fibroblasts. These observations suggest the involvement of the fimbriae as regulators of inflammatory reactions caused by
bacterial infection. Since apoptosis is an important biological phenomenon regulating the number of monocytes/macrophages at sites of
inflammation, it was of interest for us to investigate whether bacterial fimbriae play functional roles as regulators of
monocytic-cell apoptosis and to explore a possible intracellular
signaling pathway regulating the action of the fimbriae on cell apoptosis.
For this purpose, we investigated the regulatory role of the fimbriae
of P. gingivalis in serum withdrawal-induced apoptosis of
human monocytic THP-1 cells. We show in this study that P. gingivalis fimbriae inhibited serum withdrawal-induced apoptosis of THP-1 cells and that they did so via extracellular signal-regulated kinase (ERK)- and mitogen-activated protein kinase
(MAPK)-dependent expression of p21 Cip/WAF1 (p21), a cyclin-dependent
kinase inhibitor.
 |
MATERIALS AND METHODS |
Cell culture.
Human monocytic THP-1 cells were maintained in
RPMI 1640 medium supplemented with 100 µg of streptomycin sulfate/ml,
100 U of penicillin G potassium/ml, and 5% (vol/vol)
heat-inactivated fetal bovine serum (Flow Laboratories, McLean, Va.) in
a humidified atmosphere of 5% CO2 and 95% air
at 37°C. To induce apoptosis, we washed the cells five times with
serum-free medium, cultured them for 24 h in serum-free medium,
washed them three times with serum-free medium, and then incubated them
with or without the fimbriae for various times under serum withdrawal conditions.
Preparation of P. gingivalis fimbriae and their
antibody.
P. gingivalis ATCC 33277 fimbriae were
prepared and purified from cell washings by the method of Yoshimura et
al. (46) as described previously (16). We had
demonstrated earlier that purified fimbriae were able to induce several
biological activities that could not be attributed to
lipopolysaccharide contamination in the preparation
(16-18). The protein content of the fimbriae was measured
by the method of Bradford (6). A monoclonal antibody against P. gingivalis fimbriae was used, the preparation of
which was described previously (22).
Agarose gel electrophoresis for DNA fragmentation.
To assess
DNA fragmentation, we prepared DNA from the THP-1 cells and analyzed it
by the electrophoretic method. After incubation, the cells were lysed
with lysis buffer (10 mM Tris [pH 8.0], 10 mM EDTA, 0.5% Triton
X-100) for 15 min at 4°C, and then the supernatant, including DNA
fragments, was harvested from the lysate by centrifugation for 20 min
at 13,000 × g. The DNA fragments in the supernatant were precipitated with 0.5 M NaCl and ethanol, electrophoresed on a 2%
agarose gel containing ethidium bromide, and then visualized under UV light.
Quantification of DNA fragmentation.
DNA fragmentation was
measured by a slight modification of the diphenylamine assay described
previously (29). Briefly, after incubation, the cells were
scraped off the culture plates and incubated with 200 µl of lysis
buffer (10 mM Tris [pH 8.0], 10 mM EDTA, 0.5% Triton X-100) for 15 min at 4°C. Then, the intact chromatin (pellet) was separated from
DNA fragments (supernatant) by centrifugation for 20 min at 13,000 × g. The pellets were resuspended in 200 µl of the lysis
buffer, and the samples were precipitated with 1 N perchloric acid at
4°C. The DNA was pelleted at 13,000 × g for 20 min,
and the supernatant was removed. After addition of 50 µl of 1 N
perchloric acid, the samples were boiled for 20 min. The DNA contents
were quantified by use of the diphenylamine reagent (7).
The percentage of fragmented DNA was calculated as the ratio of the DNA
content in the supernatant to the amount in the pellet.
Western blot analysis.
THP-1 cells under serum-free culture
conditions were incubated in the presence or absence of test samples.
Cell lysis was achieved with lysis buffer (10 mM Tris-HCl [pH 7.9],
1% sodium deoxycholate, 1% Nonidet P-40, 0.1% sodium dodecyl
sulfate, 150 mM NaCl, 5 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride).
The samples were electrophoresed on 10.0, 15.0, or 17.5%
polyacrylamide gels by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis using a Tris-glycine buffer system (0.025 M Tris, 0.192 M glycine, 0.1% sodium dodecyl sulfate). The proteins were transferred
to a polyvinylidene difluoride membrane (Millipore Co., Bedford, Mass.)
by using the semidry transblot system (ATTO Co., Tokyo, Japan). The
blots were blocked with 5% skim milk in Tris-buffered saline including
0.1% Tween 20 (TBS-T) overnight at 4°C and then washed with TBS-T.
Then, the membrane was incubated with the primary antibody in 5% skim
milk in TBS-T overnight at 4°C. Proteins were detected with a
Phototope-HRP Western blot detection kit (New England Biolabs, Inc.,
Beverly, Mass.). The blots were exposed to X-Omat film (Eastman Kodak
Co., Rochester, N.Y.).
Antibodies and inhibitors.
The following antibodies were
used for Western blot analysis: anti-CPP32 (Santa Cruz Biotechnology,
Santa Cruz, Calif.), anti-p21 (Santa Cruz Biotechnology), anti-PARP
(Enzyme Systems Products, Livermore, Calif.), anti- MAPK, and
anti-phosphorylated p44/42 MAPK (New England Biolabs, Inc).
Secondary-antibody-horseradish peroxidase conjugates were purchased
from Santa Cruz Biotechnology and Bio-Rad Laboratories (Richmond,
Calif.). PD98059 was purchased from Calbiochem-Novabiochem Corporation
(La Jolla, Calif.). Ac-YVAD-CHO (acetyl-L-tyrosyl-L-valyl-L-alanyl-L-aspart-1-al),
a caspase-1 family inhibitor, and Ac-DEVD-CHO
(acetyl-L-aspartyl-L-glutamyl-L-valyl-L-aspart-1-al), a caspase-3 family inhibitor, were purchased from Peptide Institute, Inc. (Osaka, Japan).
Antisense oligonucleotide.
The antisense oligonucleotide
used was based on the p21 coding sequence. Antisense p21
oligonucleotide (5'-TCC CCA GCC GGT TCT GAC AT-3') is
complementary to the region around the initiation codon, and the
control sense p21 oligonucleotide (5'-ATG TCA GAA CCG GCT GGG
GA-3') is complementary to the antisense p21 oligonucleotide. Each oligonucleotide and Lipofectin (Life Technologies, Inc., Rockville, Md.) were incubated for 15 min at 37°C. The mixture was
diluted with medium to a final concentration of 0.5 or 1 µM oligonucleotide and added to the THP-1 cells.
 |
RESULTS |
P. gingivalis fimbriae inhibit THP-1 cell apoptosis
under growth factor deprivation.
In the absence of an appropriate
survival stimulus, human monocytes undergo spontaneous apoptosis
(13, 26-28). Therefore, we first looked by DNA
fragmentation assay for apoptosis of the untreated or fimbria-treated
cells under growth factor deprivation. In preliminary experiments, we
observed that the fimbriae inhibited the apoptosis of THP-1 cells under
these conditions in a dose-dependent manner (1 to 5 µg of
protein/ml), with the maximum inhibitory action at 5 µg of protein/ml
of fimbriae. Therefore, we used this fimbrial concentration in the
following experiments.
Figure 1A shows that the characteristic DNA laddering of
the cells under these conditions increases in a culture time-related manner. However, such significantly increased DNA laddering was not
observed when the medium was supplemented with 5% serum.
Interestingly, we observed that the fimbriae clearly inhibit DNA
laddering of the cells induced under growth factor deprivation. In
addition, this inhibitory action of the fimbriae was also supported by
the results of the diphenylamine assay (Fig. 1B). Furthermore, to confirm the inhibitory action of the fimbriae, we examined by DNA
fragmentation and diphenylamine assays whether the fimbrial inhibition
could be neutralized by a monoclonal antibody against the fimbriae. The
monoclonal antibody completely neutralized the fimbrial inhibition of
cell apoptosis (Fig. 1C and D).

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 1.
Inhibitory effect of P. gingivalis
fimbriae on THP-1 cell apoptosis induced by growth factor deprivation.
(A) THP-1 cells were incubated with or without serum in the absence or
presence of fimbriae at 5 µg of protein/ml. DNA fragments from the
supernatant of the lysed cells were isolated at selected times after
the initiation of the cultures and then subjected to agarose gel
electrophoresis. X174 RF DNA HaeIII fragments were
used as molecular weight markers (M). (B) The cells were
treated as described for panel A, and DNA fragmentation was quantified
by the diphenylamine assay. (C) Cells in serum-free medium were
incubated in the absence or presence of fimbriae at 5 µg of
protein/ml that had been pretreated or not with anti-fimbrial antibody
(Ab). DNA fragments from the supernatant of the lysed cells were
analyzed by agarose gel electrophoresis at 24 h after the
initiation of the cultures. (D) Cells were treated as described for
panel C, and DNA fragmentation was quantified by the diphenylamine
assay at 24 h after the initiation of the cultures. The results of
the diphenylamine assays are expressed as the mean ± standard deviation of three cultures. An identical experiment
independently performed gave similar results.
|
|
P. gingivalis fimbriae stimulate expression of p21
in THP-1 cells.
Many studies (2, 3, 15, 34, 42, 43)
have shown that expression of p21 is essential for the differentiation
and survival of several kinds of cells. Also, there is a study showing that the fimbriae were able to induce monocytic-cell differentiation (21). Therefore, we suspected the involvement of p21
expression in the fimbrial inhibition of THP-1 cell apoptosis under
growth factor deprivation. Based on this suspicion, we examined by
Western blot analysis whether the fimbriae could stimulate the
expression of p21 protein in the cells under these culture conditions.
As a result, we observed the clearly stimulated expression of p21 protein in the cells when the expression was examined at 12 or 24 h after the initiation of the fimbrial treatment (data not shown). In
addition, using an antisense p21 oligonucleotide, we confirmed the
fimbria-stimulated expression of the p21 protein. Figure
2 shows that the fimbria-stimulated expression
of the p21 protein was inhibited by antisense p21 oligonucleotide
treatment but not by sense p21 oligonucleotide. These results clearly
demonstrate that the fimbriae act as potent stimulators of p21
expression in the cells in the absence of growth factors.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 2.
Inducing effect of P. gingivalis fimbriae
on expression of p21 protein in THP-1 cells under growth factor
deprivation. THP-1 cells in serum-free medium were pretreated for
24 h in the absence or presence of 1 µM antisense or sense p21
oligonucleotide and were then incubated, also in serum-free medium, in
the absence or presence of the fimbriae at 5 µg of protein/ml. The
expression of p21 protein in the cells was analyzed by Western blotting
with anti-p21 antibody 24 h after the initiation of the fimbrial
treatment. An identical experiment independently performed gave similar
results.
|
|
On the other hand, since Bcl-2, an oncoprotein, acts as an inhibitor of
cell apoptosis, we also examined by Western blot analysis the effect of
the fimbriae on the expression of the Bcl-2 protein in THP-1 cells
under growth factor deprivation. Figure 3 shows that the
fimbriae had no effect on the expression of the Bcl-2 protein,
suggesting to us that the regulation of Bcl-2 expression is probably
not involved in the fimbrial inhibition of THP-1 cell apoptosis induced
under growth factor deprivation.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of P. gingivalis fimbriae on
expression of Bcl-2 protein in THP-1 cells under growth factor
deprivation. THP-1 cells were treated as described in the legend to
Fig. 2, and the expression of Bcl-2 protein in the cells was
analyzed by Western blotting with anti-Bcl-2 antibody 12 and 24 h
after the initiation of the cultures. An identical experiment
independently performed gave similar results.
|
|
P. gingivalis fimbriae inhibit THP-1 cell apoptosis
via p21 under growth factor deprivation.
The fimbrial stimulation
of the expression of the p21 protein in THP-1 cells suggested to us the
possibility that the p21 protein is involved in the fimbrial inhibition
of cell apoptosis under growth factor deprivation. To demonstrate the
possibility, we examined whether fimbrial inhibition is blocked by
antisense p21 oligonucleotide treatment, and we observed that the
antisense oligonucleotide at 1 µM, but not the sense oligonucleotide,
significantly blocked fimbrial inhibition of apoptosis (Fig.
4). These results indicate an important role for the p21
protein in the inhibitory action of the fimbriae on cell apoptosis
under growth factor deprivation.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 4.
Antisense p21 oligonucleotide blocks fimbrial inhibition
of THP-1 cell apoptosis induced under growth factor deprivation. THP-1
cells were treated as described in the legend to Fig. 2, and
DNA fragmentation was quantified by the diphenylamine assay 24 h
after the initiation of the fimbrial treatment. The results of the
assay are expressed as the mean ± standard deviation of three
cultures. Variations between values from the fimbria-treated groups
with or without antisense p21 oligonucleotide that were found to be
statistically significant by Student's t test are
indicated by asterisks (*, P < 0.05; **,
P < 0.01). An identical experiment independently
performed gave similar results.
|
|
P. gingivalis fimbriae inhibit THP-1 cell apoptosis
under growth factor deprivation via ERK- and MAPK-dependent expression
of p21.
Since we found the p21 protein to be involved in the
fimbrial inhibition of THP-1 cell apoptosis under growth factor
deprivation, it was of interest to us to explore which protein kinase
acts in signaling of the fimbria-stimulated expression of p21 in the cells. Interestingly, several studies (5, 25) have
suggested that p21 expression is induced by activation of ERK and MAPK. Therefore, using Western blot analysis with anti-phosphorylated p44/42
MAPK antibody, we investigated whether the fimbriae stimulated expression of p21 in THP-1 cells through activation (i.e.,
phosphorylation) of ERK and MAPK. As shown in Fig. 5,
although they had no effect on the total amount of the ERK and MAPK
proteins in THP-1 cells, the fimbriae markedly increased the expression
of the phosphorylated forms of ERK and MAPK in the cells. Since a
recent study (2) demonstrated that p21 inhibits apoptosis
of monocytic cells via inhibition of c-Jun N-terminal
kinase-stress-activated protein kinase (JNK-SAPK) activation,
we also examined whether JNK-SAPK activation was involved in THP-1 cell
apoptosis under growth factor deprivation. Although the data are not
shown, the increased expression of phosphorylated JNK-SAPK was not
observed in the absence of growth factors. In addition, our Western
blot analysis showed that the fimbria-stimulated expression of p21
protein in the cells was inhibited by PD98059, a specific inhibitor of
mitogen-activated protein-ERK kinase (MEK) activation (12)
(Fig. 6A). These observations caused to us to
investigate the effect of PD98059 on the fimbrial inhibition of cell
apoptosis. Figure 6B shows that the inhibitor blocked the fimbrial
inhibition of cell apoptosis in a dose-dependent manner. Taken
together, these results suggest that the fimbriae inhibited THP-1 cell
apoptosis under growth factor deprivation via ERK- and MAPK-dependent
expression of p21.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of P. gingivalis fimbriae on
phosphorylation of ERK and MAPK in THP-1 cells under growth factor
deprivation. The cells were treated as described in the legend to Fig.
2. The expression of ERK or phosphorylated ERK proteins in the cells
was analyzed by Western blotting with anti-p44/42 MAPK antibody or
anti-phosphorylated p44/42 MAPK antibody at selected times after the
initiation of the cultures. An identical experiment independently
performed gave similar results.
|
|

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 6.
Involvement of ERK and MAPK activity in
fimbria-stimulated expression of p21 protein in and inhibitory effect
of the fimbriae on THP-1 cell apoptosis induced under growth factor
deprivation. (A) THP-1 cells in serum-free medium were pretreated or
not for 1 h with PD98059 at 5 µM and then incubated in the
absence or presence of fimbriae at 5 µg of protein/ml. After 24 h, the expression of the p21 protein in the cells was analyzed by
Western blotting with anti-p21 antibody. (B) Cells were treated as
described for panel A, and DNA fragmentation was quantified by the
diphenylamine assay 24 h after the initiation of the fimbrial
treatment. The results of the assay are expressed as the mean ± standard deviation of three cultures. An identical experiment
independently performed gave similar results.
|
|
Caspase-3 inhibitor blocks growth factor deprivation-induced
apoptosis of THP-1 cells.
It is well demonstrated that the caspase
cascade plays an important role in the signaling of apoptosis of many
kinds of cells. Therefore, using Ac-YVAD-CHO and Ac-DEVD-CHO,
inhibitors of caspase-1 and -3, respectively, we examined which caspase
mediates THP-1 cell apoptosis under growth factor deprivation. As shown
in Fig. 7, cell apoptosis was significantly inhibited by
the caspase-3 inhibitor but not by the caspase-1 inhibitor, thus
suggesting that caspase-3 activation may be involved in cell apoptosis.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 7.
Effect of caspase inhibitors on THP-1 cell apoptosis
induced under growth factor deprivation. THP-1 cells in serum-free
medium were treated with the indicated concentration of Ac-YVAD-CHO or
Ac-DEVD-CHO or untreated. Then DNA fragmentation was quantified by the
diphenylamine assay 24 h after the initiation of the treatment.
The results of the assay are expressed as the mean ± standard
deviation of three cultures. Similar results were obtained in an
identical experiment.
|
|
P. gingivalis fimbriae inhibit growth factor
deprivation-induced caspase-3 activation in THP-1 cells via activation
of ERK and MAPK and expression of p21.
To confirm caspase-3
activation during induction of THP-1 cell apoptosis under growth factor
deprivation, we examined by Western blot analysis whether the caspase-3
proform and PARP would be cleaved in the cells under growth factor
deprivation. As shown in Fig. 8A, the caspase-3 proform
and PARP of the cells in the presence of serum were cleaved when the
cells were incubated under growth factor deprivation. However, the
fimbriae inhibited the cleavage of the caspase-3 proform and PARP in
the cells. Importantly, our interest was to explore whether the
fimbrial inhibition of caspase-3 activation would be blocked by
antisense p21 oligonucleotide and PD98059 treatment. We observed that
the fimbrial inhibition of caspase-3 activation in the cells was
blocked by antisense p21 oligonucleotide and PD98059 treatment, because
the inhibition of cleavage of the caspase-3 proform and PARP in
fimbria-treated cells was reduced by the treatment (Fig. 8B and
C).

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 8.
Inhibitory effect of P. gingivalis
fimbria-stimulated ERK and MAPK activity and expression of p21 protein
on caspase-3 activation in THP-1 cells induced under growth factor
deprivation. (A) THP-1 cells were treated as described in the legend to
Fig. 1A. (B) Cells were treated as described in the
legend to Fig. 6A. (C) Cells were treated as described
in the legend to Fig. 2. After 24 h, the cleavage of the caspase-3
proform and PARP was analyzed by Western blotting with anti-CPP32
antibody or anti-PARP antibody. An identical experiment independently
performed gave similar results.
|
|
 |
DISCUSSION |
It is of interest to investigate whether bacterial
fimbriae, important structures in the triggering of bacterial
infection, modulate apoptosis of monocytes/macrophages, cells that play
a central role in inflammatory reactions caused by pathogenic bacteria. Therefore, using fimbriae of P. gingivalis, which is a
pathogen causing periodontal disease, we investigated the regulatory
role of bacterial fimbriae in the apoptosis of cultured human monocytic THP-1 cells. The present study demonstrates that the bacterial fimbriae
inhibited THP-1 cell apoptosis under growth factor deprivation via ERK-
and MAPK-dependent expression of p21.
Growth factor deprivation has been shown to provoke apoptosis in a
variety of cells, including monocytes/macrophages and endothelial cells
(8, 9, 13, 26-28). Although the induction of monocytic apoptosis under growth factor or serum withdrawal conditions is physiologically irrelevant, these experimental conditions appear to
provide an effective method for examining the regulation of monocytic
apoptosis. Therefore, in this study, we employed this experimental
design to explore the regulation of apoptosis in THP-1 cells by
P. gingivalis fimbriae. In fact, we observed that THP-1
cells effectively undergo apoptosis upon growth factor deprivation as determined by detection of the characteristic genomic DNA laddering. The bacterial fimbriae inhibited monocytic-cell apoptosis. This inhibitory action of fimbriae was confirmed by their inability to
rescue the apoptotic cells when the fimbriae were pretreated with a
specific monoclonal antibody against themselves. To our knowledge, this
is the first demonstration that bacterial fimbriae play a functional
role as inhibitors of monocytic-cell apoptosis.
It is known that p21 is involved in DNA damage repair, differentiation,
and apoptosis, and many studies (2, 3, 15, 34, 42, 43)
have demonstrated that expression of p21 inhibits apoptosis of several
kinds of cells, such as monocytic cells, muscle cells, neuroblastoma
cells, and melanoma cells. Therefore, we explored whether p21 was
involved in the fimbrial inhibition of THP-1 cell apoptosis induced
under growth factor deprivation. Using Western blot analysis, we
observed that expression of p21 protein in the cells markedly increased
following the fimbrial treatment. The antisense p21 oligonucleotide
inhibited the fimbria-stimulated expression of the p21 protein and also
blocked the fimbrial inhibition of cell apoptosis. These observations
strongly suggest that fimbrial inhibition of cell apoptosis is mediated
by the action of the p21 protein.
Since we showed earlier that fimbrial signaling of P. gingivalis occurred via
2 integrin on
macrophages (40), our interest was in exploring a possible
intracellular signaling pathway responsible for the inhibitory effects
of the fimbriae on the apoptotic cells. A recent study
(36) demonstrated that lipopolysaccharide inhibited growth
factor withdrawal-induced apoptosis of dendritic cells via an ERK- and
MAPK-dependent pathway. Therefore, we investigated the possibility that
the fimbriae inhibited serum withdrawal-induced apoptosis via the ERK-
and MAPK-dependent expression of p21. Our Western blot analysis using
phosphospecific antibody against ERK and MAPK showed that the fimbriae
increased the phosphorylation of ERK and MAPK in the cells at 6 h
after the initiation of the treatment and that this increase was
sustained up to 24 h. However, the total amount of the ERK and
MAPK proteins was not affected by the fimbriae within the period
tested. Using PD98059, a MEK1-specific inhibitor, we addressed whether
the increased phosphorylation of ERK and MAPK was MEK dependent. The
fimbrial inhibition of the apoptotic cells was blocked by the
inhibitor. In addition, the fimbrial stimulation of p21 expression in
the cells was inhibited by PD98059 treatment. Since PD98059 has little
effect on other kinases, including cyclic-AMP-dependent kinase, protein
kinase C, and other serine and threonine kinases, these results suggest that the fimbrial inhibition of cell apoptosis under growth factor deprivation is mediated by the phosphorylated ERK- and MAPK-dependent expression of p21.
On the other hand, Bcl-2 prevents apoptosis induced by a wide range of
agents. Our Western blot analysis showed that there was no change in
expression of the Bcl-2 protein following fimbrial treatment. Several
studies (33, 45) have demonstrated that protection from
apoptosis stimuli is not determined simply by Bcl-2 expression per se
but by heterodimers of Bcl-2 and its homologues. Although other members
of the Bcl-2 family were not examined here, Bcl-2 protein expression
probably does not contribute to the fimbrial inhibition of growth
factor withdrawal-induced apoptosis of the cells.
In addition, our interest was to identify the target molecule of the
p21 protein that contributes to the fimbrial inhibition of THP-1 cell
apoptosis under growth factor deprivation. In order to
elucidate this point, it was important for us to address the question
of which molecule plays a central role in the induction of cell
apoptosis. A recent study (13) demonstrated that caspase-3 plays an important role in spontaneous monocytic-cell apoptosis. In
this study, we observed that Ac-DEVD-CHO, a potent inhibitor of
caspase-3, significantly blocked growth factor withdrawal-induced cell
apoptosis. However, such blockage was not observed with Ac-YVAD-CHO, a
caspase-1 inhibitor. These observations suggest an important role for
caspase-3 in cell apoptosis under growth factor deprivation. Interestingly, recent studies (38, 39) have shown that p21 acts as a caspase-3 inactivator. Therefore, we assumed that caspase-3 might be a target molecule of the p21 protein that contributes to the
fimbrial inhibition of THP-1 cell apoptosis. As expected, the fimbriae
inhibited caspase-3 activity of the cells induced by the absence of
serum. And, interestingly, the fimbrial inhibition of caspase-3
activity was blocked by PD98059 and antisense p21 oligonucleotide
treatment. These results strongly suggest that caspase-3 is a target
molecule of p21 that mediates the fimbrial inhibition of THP-1 cell
apoptosis under growth factor deprivation.
In view of the signaling pathway of the fimbriae described above,
although it is of interest to demonstrate whether the fimbria-induced ERK-p21-caspase-3 signaling pathway is mediated via binding of the
fimbriae to
2 integrin, as suggested by our
previous study (40), this point still remains obscure.
An understanding of the processes regulating apoptosis of
monocytes/macrophages is critical to the elucidation of the pathogenic mechanism of chronic inflammation. Although the inflammatory reaction in bacterial infection has been well demonstrated, we suggest here that
bacterial fimbriae act as inhibitors of growth factor withdrawal-induced apoptosis of cultured monocytic cells through p21
expression via the ERK- and MAPK-dependent pathway. This action suggests that bacterial fimbriae play a functional role as potent regulators of chronic inflammatory disease, such as periodontal disease
caused by periodontal pathogens.
In conclusion, the present study shows that P. gingivalis
fimbriae inhibit caspase-3-mediated apoptosis of monocytic THP-1 cells
under growth factor deprivation via ERK- and MAPK-dependent expression
of p21.
 |
ACKNOWLEDGMENT |
This work was supported by a grant-in-aid for scientific research
(11470380) from the Ministry of Education, Science, and Culture of Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of Oral
Infectious Diseases and Immunology, Faculty of Dental Science, Kyushu University, Maidashi 3-1-1, Higashi-Ku, Fukuoka City 812-8582, Japan. Phone and fax: 81-92-642-6331. E-mail:
hanazawa{at}dent.kyushu-u.ac.jp.
Editor:
V. J. DiRita
 |
REFERENCES |
| 1.
|
Albina, J. E.,
S. Cui,
R. B. Mateo, and J. S. Reichner.
1993.
Nitric oxide-mediated apoptosis in murine peritoneal macrophages.
J. Immunol.
150:5080-5085[Abstract].
|
| 2.
|
Asada, M.,
T. Yamada,
H. Ichijo,
D. Delia,
K. Miyazono,
K. Fukumuro, and S. Mizutani.
1999.
Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation.
EMBO J.
18:1223-1234[CrossRef][Medline].
|
| 3.
|
Asada, M.,
T. Yamada,
K. Fukumuro, and S. Mizutani.
1998.
p21Cip/WAF1 is important for differentiation and survival of U937 cells.
Leukemia
12:1944-1950[CrossRef][Medline].
|
| 4.
|
Ashkenazi, A., and V. M. Dixit.
1998.
Death receptors: signaling and modulation.
Science
281:1305-1308[Abstract/Free Full Text].
|
| 5.
|
Auer, K. L.,
M. S. Spector,
R. M. Tombes,
P. Seth,
P. B. Fisher,
B. Gao,
P. Dent, and G. Kunos.
1998.
-Adrenergic inhibiton of proliferation in HepG2 cells stably transfected with the 1B-adrenergic receptor through a p42MAP kinase/p21Cip1/WAF1-dependent pathway.
FEBS Lett.
436:131-138[CrossRef][Medline].
|
| 6.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[CrossRef][Medline].
|
| 7.
|
Burton, K.
1956.
A study of the conditions and mechanism of the diphenylamine reaction for the estimation of DNA.
Biochem. J.
62:315-323[Medline].
|
| 8.
|
Chin, B. Y.,
I. Petrache,
A. M. K. Choi, and M. E. Choi.
1999.
Transforming growth factor 1 rescues serum deprivation-induced apoptosis via the mitogen-activated protein kinase (MAPK) pathway in macrophages.
J. Biol. Chem.
274:11362-11368[Abstract/Free Full Text].
|
| 9.
|
Choi, M. E., and B. J. Ballermann.
1995.
Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor- .
J. Biol. Chem.
270:21144-21150[Abstract/Free Full Text].
|
| 10.
|
Colotta, F.,
F. Re,
N. Polentarutti,
S. Sozzani, and A. Mantovani.
1992.
Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.
Blood
80:2012-2020[Abstract/Free Full Text].
|
| 11.
|
Connell, H.,
M. Hedlund,
W. Agace, and C. Svanborg.
1997.
Bacterial attachment to uro-epithelial cells: mechanisms and consequences.
Adv. Dent. Res.
11:50-58[Abstract].
|
| 12.
|
Dudly, D. T.,
L. Pang,
S. J. Decker,
A. J. Bridges, and A. R. Saltiet.
1995.
A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Proc. Natl. Acad. Sci. USA
92:7686-7689[Abstract/Free Full Text].
|
| 13.
|
Fahy, R. J.,
A. I. Doseff, and M. D. Wewers.
1999.
Spontaneous human monocyte apoptosis utilizes a caspase-3-dependent pathway that is blocked by endotoxin and is independent of caspase-1.
J. Immunol.
163:1755-1762[Abstract/Free Full Text].
|
| 14.
|
Genco, C. A.,
T. Van Dyke, and S. Amar.
1998.
Animal models for Porphyromonas gingivalis-mediated periodontal disease.
Trends Microbiol.
6:444-449[CrossRef][Medline].
|
| 15.
|
Gorospe, M.,
C. Cirielli,
X. Wang,
P. Seth,
M. C. Capogrossi, and N. J. Holbrook.
1997.
p21 (Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells.
Oncogene
14:929-935[CrossRef][Medline].
|
| 16.
|
Hanazawa, S.,
K. Hirose,
Y. Ohmori,
S. Amano, and S. Kitano.
1988.
Bacteroides gingivalis fimbriae stimulate production of thymocyte-activating factor by human gingival fibroblasts.
Infect. Immun.
56:272-274[Abstract/Free Full Text].
|
| 17.
|
Hanazawa, S.,
Y. Murakami,
A. Takeshita,
H. Kitami,
K. Ohta,
S. Amano, and S. Kitano.
1992.
Porphyromonas gingivalis fimbriae induce expression of the neutrophil chemotactic factor KC gene of mouse peritoneal macrophages: role of protein kinase C.
Infect. Immun.
60:1544-1549[Abstract/Free Full Text].
|
| 18.
|
Hanazawa, S.,
Y. Murakami,
K. Hirose,
S. Amano,
Y. Ohmori,
H. Higuchi, and S. Kitano.
1991.
Bacteroides (Porphyromonas) gingivalis fimbriae activate mouse peritoneal macrophages and induce gene expression and production of interleukin-1.
Infect. Immun.
59:1972-1977[Abstract/Free Full Text].
|
| 19.
|
Hedges, S.,
M. Svensson, and C. Svanborg.
1992.
Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro.
Infect. Immun.
60:1295-1301[Abstract/Free Full Text].
|
| 20.
|
Hiroi, M.,
T. Shimojima,
M. Kashimata,
T. Miyata,
H. Takano,
M. Takahama, and H. Sakagami.
1998.
Inhibition by Porphyromonas gingivalis LPS of apoptosis induction in human peripheral blood polymorphonuclear leukocytes.
Anticancer Res.
18:3475-3479[Medline].
|
| 21.
|
Hirose, K.,
E. Isogai,
H. Mizugai, and I. Ueda.
1996.
Inductive effect of Porphyromonas gingivalis fimbriae on differentiation of human monocytic tumor cell line U937.
Oral Microbiol. Immunol.
11:62-64[Medline].
|
| 22.
|
Kawata, Y.,
S. Hanazawa,
S. Amano,
Y. Murakami,
T. Matsumoto,
K. Nishida, and S. Kitano.
1994.
Porphyromonas gingivalis fimbriae stimulate bone resorption in vitro.
Infect. Immun.
62:3012-3016[Abstract/Free Full Text].
|
| 23.
|
Lamont, R. J., and H. F. Jenkinson.
1998.
Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis.
Microbiol. Mol. Biol. Rev.
62:1244-1263[Abstract/Free Full Text].
|
| 24.
|
Landi, L.,
S. Amar,
A. S. Polins, and T. E. Van Dyke.
1997.
Host mechanisms in the pathogenesis of periodontal disease.
Curr. Opin. Periodontol.
4:3-10[Medline].
|
| 25.
|
Liu, Y.,
J. L. Martindale,
M. Gorospe, and N. J. Holbrook.
1996.
Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway.
Cancer Res.
56:31-35[Abstract/Free Full Text].
|
| 26.
|
Mangan, D. F.,
G. R. Welch, and S. M. Wahl.
1991.
Lipopolysaccharide, tumor necrosis factor- , and IL-1 prevent programmed cell death (apoptosis) in human peripheral blood monocytes.
J. Immunol.
146:1541-1546[Abstract].
|
| 27.
|
Mangan, D. F.,
S. E. Mergenhagen, and S. M. Wahl.
1993.
Apoptosis in human monocytes: possible role in chronic inflammatory disease.
J. Periodontol.
64:461-466[Medline].
|
| 28.
|
Mangan, D. F., and S. M. Wahl.
1991.
Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines.
J. Immunol.
147:3408-3412[Abstract].
|
| 29.
|
McConkey, D. J.,
P. Nicotera,
P. Hartzell,
G. Bellomo,
A. H. Wyllie, and S. Orrenius.
1989.
Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration.
Arch. Biochem. Biophys.
269:365-370[CrossRef][Medline].
|
| 30.
|
Moore, K. J., and G. Matlashewski.
1994.
Intracellular infection by Leishmania donovani inhibits macrophage apoptosis.
J. Immunol.
152:2930-2937[Abstract].
|
| 31.
|
Murakami, Y.,
H. Iwahashi,
H. Yasuda,
T. Umemoto,
I. Namikawa,
S. Kitano, and S. Hanazawa.
1996.
Porphyromonas gingivalis fimbrillin is one of the fibronectin-binding proteins.
Infect. Immun.
64:2571-2576[Abstract].
|
| 32.
|
Muro, M.,
K. Nakashima,
J. Tomioka,
S. Kato,
K. Nonaka,
T. Yoshida,
M. Inoue,
T. Nishihara, and Y. Kowashi.
1999.
Inhibitory effect of lipopolysaccharide on apoptotic cell death in macrophages infected with Actinobacillus actinomycetemcomitans.
FEMS. Microbiol. Lett.
175:211-216[CrossRef][Medline].
|
| 33.
|
Oltvai, Z. N.,
C. L. Milliman, and S. J. Korsmeyer.
1993.
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.
Cell
74:609-619[CrossRef][Medline].
|
| 34.
|
Poluha, W.,
D. K. Poluha,
B. Chang,
N. E. Crosbie,
C. M. Schonhoff,
D. L. Kilpatrick, and A. H. Ross.
1996.
The cyclin-dependent kinase inhibitor p21WAF1 is required for survival of differentiating neuroblastoma cells.
Mol. Cell. Biol.
16:1335-1341[Abstract].
|
| 35.
|
Preshaw, P. M.,
R. E. Schifferle, and J. D. Walters.
1999.
Porphyromonas gingivalis lipopolysaccharide delays human polymorphonuclear leukocyte apoptosis in vitro.
J. Periodontal Res.
34:197-202[CrossRef][Medline].
|
| 36.
|
Rescigno, M.,
M. Martino,
C. L. Sutherland,
M. R. Gold, and P. Ricciardi-Castagnoli.
1998.
Dendritic cell survival and maturation are regulated by different signaling pathways.
J. Exp. Med.
188:2175-2180[Abstract/Free Full Text].
|
| 37.
|
Steller, H.
1995.
Mechanisms and genes of cellular suicide.
Science
267:1445-1449[Abstract/Free Full Text].
|
| 38.
|
Suzuki, A.,
Y. Tsutomi,
K. Akahane,
T. Araki, and M. Miura.
1998.
Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP.
Oncogene
17:931-940[CrossRef][Medline].
|
| 39.
|
Suzuki, A.,
Y. Tsutomi,
N. Yamamoto,
T. Shibutani, and K. Akahane.
1999.
Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death.
Mol. Cell. Biol.
19:3842-3847[Abstract/Free Full Text].
|
| 40.
|
Takeshita, A.,
Y. Murakami,
Y. Yamashita,
M. Ishida,
S. Fujisawa,
S. Kitano, and S. Hanazawa.
1998.
Porphyromonas gingivalis fimbriae use 2 integrin (CD11/CD18) on mouse peritoneal macrophages as a cellular receptor, and the CD18 chain plays a functional role in fimbrial signaling.
Infect. Immun.
66:4056-4060[Abstract/Free Full Text].
|
| 41.
|
Van Winkelhoff, A. J., and J. de Graaff.
1991.
Microbiology in the management of destructive periodontal disease.
J. Clin. Periodontol.
18:406-410[CrossRef][Medline].
|
| 42.
|
Wang, J., and K. Walsh.
1996.
Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation.
Science
273:359-361[Abstract].
|
| 43.
|
Wang, Z.,
G. Van Tuyle,
D. Conard,
P. B. Fisher,
P. Dent, and S. Grant.
1999.
Dysregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDM6 increases the susceptibility of human leukemia cells (U937) to 1- -D- arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
Cancer Res.
59:1259-1267[Abstract/Free Full Text].
|
| 44.
|
William, R.,
G. Watson,
O. D. Rotstein,
J. Parodo,
R. Bitar, and J. C. Marshall.
1998.
The IL-1 -converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1 .
J. Immunol.
161:957-962[Abstract/Free Full Text].
|
| 45.
|
Yang, E.,
J. Zha,
J. Jockel,
L. M. Boise,
C. B. Thompson, and S. J. Korsmeyer.
1995.
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death.
Cell
80:285-291[CrossRef][Medline].
|
| 46.
|
Yoshimura, F.,
K. Takahashi,
Y. Nodasaka, and T. Suzuki.
1984.
Purification and characterization of a novel type of fimbriae from the oral anaerobe Bacteroides gingivalis.
J. Bacteriol.
160:949-954[Abstract/Free Full Text].
|
| 47.
|
Zambon, J. J.
1996.
Periodontal diseases: microbial factors.
Ann. Periodontol.
1:879-925[Medline].
|
| 48.
|
Zychlinsky, A., and P. Sansonetti.
1997.
Perspectives series: host/pathogen interactions.
J. Clin. Investig.
100:493-496[Medline].
|
Infection and Immunity, August 2001, p. 4944-4950, Vol. 69, No. 8
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.4944-4950.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ghosh, A., Park, J. Y., Fenno, C., Kapila, Y. L.
(2008). Porphyromonas gingivalis, Gamma Interferon, and a Proapoptotic Fibronectin Matrix Form a Synergistic Trio That Induces c-Jun N-Terminal Kinase 1-Mediated Nitric Oxide Generation and Cell Death. Infect. Immun.
76: 5514-5523
[Abstract]
[Full Text]
-
Yilmaz, O.
(2008). The chronicles of Porphyromonas gingivalis: the microbium, the human oral epithelium and their interplay. Microbiology
154: 2897-2903
[Abstract]
[Full Text]
-
Zhou, Q., Amar, S.
(2006). Identification of Proteins Differentially Expressed in Human Monocytes Exposed to Porphyromonas gingivalis and Its Purified Components by High-Throughput Immunoblotting. Infect. Immun.
74: 1204-1214
[Abstract]
[Full Text]
-
Yilmaz, O., Jungas, T., Verbeke, P., Ojcius, D. M.
(2004). Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway Contributes to Survival of Primary Epithelial Cells Infected with the Periodontal Pathogen Porphyromonas gingivalis. Infect. Immun.
72: 3743-3751
[Abstract]
[Full Text]
-
Yamaguchi, N., Kubo, C., Masuhiro, Y., Lally, E. T., Koga, T., Hanazawa, S.
(2004). Tumor Necrosis Factor Alpha Enhances Actinobacillus actinomycetemcomitans Leukotoxin-Induced HL-60 Cell Apoptosis by Stimulating Lymphocyte Function-Associated Antigen 1 Expression{dagger}. Infect. Immun.
72: 269-276
[Abstract]
[Full Text]
-
Fukuda, S., Mantel, C. R., Pelus, L. M.
(2004). Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways. Blood
103: 120-127
[Abstract]
[Full Text]